1. Aframian, D.J., Helcer, M., Livni, D., Robinson, S.D., Markitziu, A., and Nadler, C. (2007). Pilocarpine treatment in a mixed cohort of xerostomic patients. Oral Dis 13, 88-92.
2. Astor, F.C., Hanft, K.L., and Ciocon, J.O. (1999). Xerostomia: a prevalent condition in the elderly. Ear Nose Throat J 78, 476-479.
3. Atkinson, J.C., Grisius, M., and Massey, W. (2005). Salivary hypofunction and xerostomia: diagnosis and treatment. Dent Clin North Am 49, 309-326.
4. Bagheri, H., Schmitt, L., Berlan, M., and Montastruc, J.L. (1997). A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs. Eur J Clin Pharmacol 52, 339-342.
5. Bergdahl, M., and Bergdahl, J. (2000). Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res 79, 1652-1658.
6. Braga, M.A., Tarzia, O., Bergamaschi, C.C., Santos, F.A., Andrade, E.D., and Groppo, F.C. (2009). Comparison of the effects of pilocarpine and cevimeline on salivary flow. Int J Dent Hyg 7, 126-130.
7. Cassolato, S.F., and Turnbull, R.S. (2003). Xerostomia: clinical aspects and treatment. Gerodontology 20, 64-77.
8. Dirix, P., Nuyts, S., and Van Den Bogaert, W. (2006). Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107, 2525-2534.
9. Fox, R.I., Stern, M., and Michelson, P. (2000). Update in Sjogren syndrome. Curr Opin Rheumatol 12, 391-398.
10. Furness, S., Bryan, G., Mcmillan, R., and Worthington, H.V. (2013). Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev, CD009603.
11. Furness, S., Worthington, H.V., Bryan, G., Birchenough, S., and Mcmillan, R. (2011). Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev, CD008934.
12. Gomez-Moreno, G., Aguilar-Salvatierra, A., Guardia, J., Uribe-Marioni, A., Cabrera-Ayala, M., Delgado-Ruiz, R.A., and Calvo-Guirado, J.L. (2013). The efficacy of a topical sialogogue spray containing 1% malic acid in patients with antidepressant-induced dry mouth: a double-blind, randomized clinical trial. Depress Anxiety 30, 137-142.
13. Gu, J., Zhu, S., Li, X., Wu, H., Li, Y., and Hua, F. (2014). Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials. PLoS One 9, e95968.
14. Guggenheimer, J., and Moore, P.A. (2003). Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 134, 61-69; quiz 118-119.
15. Gupta, A., Epstein, J.B., and Sroussi, H. (2006). Hyposalivation in elderly patients. J Can Dent Assoc 72, 841-846.
16. Hahnel, S., Behr, M., Handel, G., and Burgers, R. (2009). Saliva substitutes for the treatment of radiation-induced xerostomia--a review. Support Care Cancer 17, 1331-1343.
17. Humphrey, S.P., and Williamson, R.T. (2001). A review of saliva: normal composition, flow, and function. J Prosthet Dent 85, 162-169.
18. Jham, B.C., Teixeira, I.V., Aboud, C.G., Carvalho, A.L., Coelho Mde, M., and Freire, A.R. (2007). A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer. Oral Oncol 43, 137-142.
19. Kruszka, P., and O'brian, R.J. (2009). Diagnosis and management of Sjogren syndrome. Am Fam Physician 79, 465-470.
20. Leal, S.C., Bittar, J., Portugal, A., Falcao, D.P., Faber, J., and Zanotta, P. (2010). Medication in elderly people: its influence on salivary pattern, signs and symptoms of dry mouth. Gerodontology 27, 129-133.
21. Lenander-Lumikari, M., and Loimaranta, V. (2000). Saliva and dental caries. Adv Dent Res 14, 40-47.
22. Navazesh, M. (1993). Methods for collecting saliva. Ann N Y Acad Sci 694, 72-77.
23. Navazesh, M., and Kumar, S.K. (2009). Xerostomia: prevalence, diagnosis, and management. Compend Contin Educ Dent 30, 326-328, 331-322; quiz 333-324.
24. Radvansky, L.J., Pace, M.B., and Siddiqui, A. (2013). Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia. Am J Health Syst Pharm 70, 1025-1032.
25. Saleh, J., Figueiredo, M.A., Cherubini, K., and Salum, F.G. (2015). Salivary hypofunction: an update on aetiology, diagnosis and therapeutics. Arch Oral Biol 60, 242-255.
26. Smith, C.H., Boland, B., Daureeawoo, Y., Donaldson, E., Small, K., and Tuomainen, J. (2013). Effect of aging on stimulated salivary flow in adults. J Am Geriatr Soc 61, 805-808.
27. Teguh, D.N., Levendag, P.C., Noever, I., Voet, P., Van Der Est, H., Van Rooij, P., Dumans, A.G., De Boer, M.F., Van Der Huls, M.P., Sterk, W., and Schmitz, P.I. (2009). Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 75, 711-716.
28. Van Der Reijden, W.A., Vissink, A., Veerman, E.C., and Amerongen, A.V. (1999). Treatment of oral dryness related complaints (xerostomia) in Sjogren's syndrome. Ann Rheum Dis 58, 465-474.
29. Villa, A., Wolff, A., Aframian, D., Vissink, A., Ekstrom, J., Proctor, G., Mcgowan, R., Narayana, N., Aliko, A., Sia, Y.W., Joshi, R.K., Jensen, S.B., Kerr, A.R., Dawes, C., and Pedersen, A.M. (2015). World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral Investig 19, 1563-1580.
30. Weber, J., and Keating, G.M. (2008). Cevimeline. Drugs 68, 1691-1698.